Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA-Reference-Cited by-同舟云学术

Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA

Published:2013-09 Issue:1-3 Volume:715 Page:405-413
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Chan Hugh H.N.,Kumar Saravana,Zhuo Lang

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease;Ago;Neuropharmacology,2011

2. The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells;Beck;Neurosci. Lett.,2006

3. Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease;Broom;Free Radical Biol. Med.,2011

4. Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior;Carman;Brain Res.,1991

5. Neuroprotection and functional recovery associated with decreased microglial activation following selective activation of mGluR2/3 receptors in a rodent model of Parkinson's disease;Chan;Parkinsons Dis. pii,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Quinone Reductase 2 Implication in Mechanism of Antiparkinsonian Action of Afobazole;Neurochemical Journal;2020-04

2. Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease;Scientific Reports;2019-11-19

3. Afobazole Restores the Dopamine Level in a 6-Hydroxydopamine Model of Parkinson’s Disease;Neurochemical Journal;2019-01

4. Imidazolium salts as innovative agents against Leishmania amazonensis;International Immunopharmacology;2018-10

5. A novel selective MAO-B inhibitor with neuroprotective and anti-Parkinsonian properties;European Journal of Pharmacology;2018-01